GlassScriptPhysician profile
Jared Patrick Steinberger
NPI 1497241350
$8,516.27
in general payments reported to CMS, 2019-2025
23 companies · $2,650 in 2025
The $2,650 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.74 · 2021: $716 · 2022: $1,292 · 2023: $1,604 · 2024: $2,238 · 2025: $2,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,943 · Travel and Lodging: $2,386 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,943.31 |
| Travel and Lodging | $2,385.59 |
| Education | $162.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,106.96 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $1,775.19 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Hawkone |
| Abbott Laboratories | $1,091.49 | 2023-2025 | Amplatzer Amulet, Dragonfly Opstar, Perclose Proglide |
| Amgen INC. | $723.44 | 2021-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $642.70 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $437.99 | 2021-2024 | Rotablator Rotational Atherectomy System Console Kit, Watchman Access System |
| Penumbra, INC. | $295.49 | 2021-2024 | Penumbra System |
| Janssen Pharmaceuticals, INC | $282.39 | 2021-2023 | Xarelto |
| Abiomed | $150.88 | 2022-2023 | Impella |
| Angiodynamics, INC. | $144.50 | 2024 | Alphavac |
| Philips North America LLC | $143.40 | 2023-2024 | (Ao0) Igt Devices Intracardiac |
| E.R. Squibb & Sons, L.L.C. | $123.97 | 2021 | |
| Impulse Dynamics (USA) INC. | $122.20 | 2024 | Optimizer |
| Inari Medical, INC. | $103.28 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genzyme Corporation | $83.33 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $76.59 | 2022 | |
| Merck Sharp & Dohme LLC | $70.65 | 2022 | |
| Chiesi USA, INC. | $39.05 | 2023-2024 | Cleviprex, Kengreal |
| Astrazeneca Pharmaceuticals LP | $28.75 | 2024 | Wainua |
| Janssen Scientific Affairs, LLC | $20.10 | 2023 | Xarelto |
| Pfizer INC. | $19.93 | 2025 | |
| Terumo Medical Corporation | $17.06 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $16.93 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Steinberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.